What if we could intervene before Afib begins?

The BoxX-NoAF trial is exploring whether cardiac ablation and LAA exclusion performed during planned cardiac surgery could reduce new-onset Afib in patients with risk factors but no history of Afib.

As we continue to better understand the risks of Afib, research like this could help shape the future of prevention.

<a href='https://www.linkedin.com/feed/hashtag/?keywords=ClinicalTrial&highlight…; target='_blank'>#ClinicalTrial</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=Afib&highlightedUpdateU…; target='_blank'>#Afib</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=CardiacSurgery&highligh…; target='_blank'>#CardiacSurgery</a>